Effects of Captopril on Cardiac and Renal Damage, and Metabolic Alterations in the Nitric Oxide-Deficient Hypertensive Rat
Authors:
- Mahmoud M. KhattabMKMahmoud M. Khattab
- Adel MostafaAMAdel Mostafa
- Othman Al-ShabanahOAOthman Al-Shabanah
- 1 December 2005
- journal article
- research article
- Published by S. Karger AG in Kidney and Blood Pressure Research
- Vol. 28 (4) , 243-250
Abstract
Chronic inhibition of nitric oxide (NO) synthesis is characterized by increased blood pressure accompanied with both cardiac hypertrophy as well as renal damage. We investigated whether the angiotensin-converting enzyme (ACE) inhibitor captopril can inhibit the cardiac hypertrophy and reverse the renal failure. We tested the influence of captopril on the nitrate-nitrite (NOx) in plasma and heart and kidney tissues. Oxidative stress, in terms of glutathione and thiobarbituric acid-reactive substances measured as malondialdehyde, was monitored examining their involvement in the cardioprotective and renoproptective actions. Three groups of Wistar rats were used: untreated group, and rats treated with the NO synthase inhibitor Nw-nitro-L-arginine methyl ester (L-NAME) and L-NAME plus captopril (10 mg/kg/day). Systolic, diastolic and mean blood pressure (BPs, BPd and BPm respectively) was measured weekly in addition to the heart rate using rat-tail plethysmography. After 3 weeks, L-NAME significantly increased BPs, BPd and BPm. Captopril treatment reversed the increments in pressure back to normal values by the fourth week. ACE inhibition by captopril reverted the L-NAME-induced hypertrophy and inhibited the enzymatic indices of cardiac damage (glutamate oxaloacetate transaminase and lactate dehydrogenase) back to normal values. Furthermore, the NO synthesis inhibition produced renal damage as indicated by significant increase in creatinine. Captopril ameliorated the raised creatinine to normal. Chronic L-NAME treatment increased serum NOx levels but concomitant treatment with captopril was without effect.Keywords
This publication has 31 references indexed in Scilit:
- Release of Nitric Oxide After Acute HypertensionJournal of Cardiovascular Pharmacology, 2000
- Molecular Plasticity of Vascular Wall During N G -Nitro- l -Arginine Methyl Ester–Induced HypertensionHypertension, 2000
- Regression of Chronic L -NAME-Treatment-induced Left Ventricular Hypertrophy: Effect of CaptoprilJournal of Molecular and Cellular Cardiology, 2000
- Effect of Captopril in L‐Name‐Induced Hypertension on the Rat Myocardium, Aorta, Brain and KidneyExperimental Physiology, 1999
- Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: evidence for a causal linkClinical Science, 1999
- Chronic Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor BlockadeHypertension, 1997
- Protein Remodelling of the Heart in NO-deficient Hypertension: The Effect of CaptoprilJournal of Molecular and Cellular Cardiology, 1997
- Effects of Sulphydryl-and Non-Sulphydryl-Containing ACE Inhibitors on Left Ventricular Relaxation in the Isolated Guinea Pig HeartEndothelium, 1997
- Nitric Oxide and the Depressor Response to Angiotensin Blockade in HypertensionHypertension, 1996
- Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.Hypertension, 1992